Health Insurance (Section 3C Pathology Services – COVID-19) Amendment (No. 2) Determination 2020
I, DAVID WEISS, delegate of the Minister for Health, make the following determination
Dated 31 March 2020
David Weiss
First Assistant Secretary
Medical Benefits Division
Health Financing Group
Department of Health
Contents
1. Name....................................................................................................................................... 1
2. Commencement....................................................................................................................... 1
3. Amendment of Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020 1
4. Authority................................................................................................................................. 1
Schedule 1 – Amendment 2
1. Name
This instrument is the Health Insurance (Section 3C Pathology Services – COVID-19) Amendment (No. 2) Determination 2020
2. Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information |
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 April 2020 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3. Amendment of Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020
Schedule 1 amends the Health Insurance (Section 3C Pathology Services – COVID‑19) Determination 2020.
4. Authority
This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.
Schedule 1 – Amendment
[1] Section 7
Revoke subsection (1) and substitute:
(1) Clause 1.7 of the pathology services table shall have effect as if items 69476, 69477, 69479, 69480 of this Determination were specified in paragraph 1.7(2)(a) of the pathology services table.
(2) Where a service is performed in circumstances described in item 69479 then item 69480 cannot be claimed.
[2] Schedule 1 – relevant services
Revoke the table and substitute:
| Group P3 – Microbiology | |
| Column 1 | Column 2 | Column 3 |
| Item | Pathology service | Fee ($) |
| 69476 | Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where: (a) the person was a private patient in a recognised hospital; or (b) the person received the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485 | 21.25 |
| 69477 | Detection of a SARS-CoV-2 nucleic acid 1 or more tests if the service was bulk-billed between 13 March 2020 and 31 March 2020 where: (a) the person was not a private patient in a recognised hospital; or (b) the person did not receive the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Supplementary item in addition to item 69485 | 71.25 |
| 69479 | Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory as described in 2.10.1 of the Pathology Services Table Where the service is bulk-billed. | 50.00 |
| 69480 | Detection of a SARS-CoV-2 nucleic acid 1 or more tests if: (a) the service is not covered by item 69479 Where the service is bulk billed | 100.00 |
| | | |
Note: The payments mentioned in Column 3 for items 69476 and 69477 are additional payments for providing SARS-COV-2 testing under previous item 69485 during the time period mentioned in Column 2.